- All sections
- G - Physics
- G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
- G16B 15/30 - Drug targeting using structural data; Docking or binding prediction
Patent holdings for IPC class G16B 15/30
Total number of patents in this class: 606
10-year publication summary
1
|
8
|
4
|
7
|
39
|
39
|
65
|
123
|
167
|
100
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
NEC Laboratories America, Inc. | 1018 |
20 |
Genentech, Inc. | 3754 |
19 |
DeepMind Technologies Limited | 856 |
14 |
Pythia Labs, Inc. | 10 |
10 |
Tencent Technology (Shenzhen) Company Limited | 13495 |
9 |
The Board of Trustees of the Leland Stanford Junior University | 6114 |
8 |
Flagship Pioneering Innovations VI, LLC. | 333 |
8 |
FUJIFILM Corporation | 27478 |
7 |
Regeneron Pharmaceuticals, Inc. | 3825 |
7 |
X Development LLC | 1393 |
7 |
The Broad Institute, Inc. | 1638 |
6 |
Cyclica Inc. | 12 |
6 |
Deargen Inc. | 25 |
6 |
NEC Oncoimmunity AS | 14 |
6 |
International Business Machines Corporation | 59199 |
5 |
Fujitsu Limited | 18875 |
5 |
Massachusetts Institute of Technology | 9837 |
5 |
Ecole Polytechnique Federale de Lausanne (epfl) | 1471 |
5 |
Innoplexus AG | 126 |
5 |
Benevolentai Technology Limited | 59 |
5 |
Other owners | 443 |